Amdavad

Municipal Corporation

LOGIN

Revised National TB Control Programme

Introduction

Revised National TB programme implemented from 24/03/1999. Under this programme, the diagnosis (free diagnosis of tuberculosis at DMC level / CBNAAT diagnosis (MDR), and XDR) and treatment of Tuberculosis is provided free of cost as per the DOTS guideline.

AMC population are divided 10 TU. Each TU have 1 MOTU, 1 STS, 1 STLS, 5 TBHV and 1 DMC at one lakh population.

Objective of this programme is to identify suspected patient of tuberculosis and diagnose them and provide the tuberculosis treatment. Target is to achieve 70% case detection and 85% cure Rate.

Cartridge Based Nucleic Acid Amplification Test (CBNAAT)

cbnaat

Initiatives taken by the Department

  • To achieve and maintained Case detection, cure and conversion. Department arranges IEC, street play, puppet show, CME of private practioners, as well as notification of doctor and patient.
  • Advertise on auto-rickshaw hood and landline number given as a help-line number for community awareness.
  • 0 based XDR suspect and send the sputum IRL of the MDR cases confirm from date 16/6-2014.
auto

Important Notice

People are requested to give sputum if they have >2 week cough and take regular DOTS, if they have tuberculosis.

Achievement of Revised National TB Control Programme

Year Total Pateints Put on DOTS
2010 8906
2011 8326
2012 8361
2013 8520
2014 4665 (up to 30/06/2014)
  • MDR patients put on DOTS from 07/07/2007 to 31/12/2013 = 1187
  • MDR patients put on DOTS from 01/01/2014 to 30/06/2014 = 198
  • XDR patients put on DOTS from 19/03/2012 to 30/06/2014 = 72

Human Resources

Sr. No. Category of Staff Sanctioned
1 City TB Officer 1
2 MO DTC 1
3 MO Med.College 3
4 MOTC 10
5 STS 10
6 STLS 10
7 Lab. Technician 53
8 Pharmacist 1
9 DEO 1
10 TBHV 54
11 DPS 1
Total 144
Home | About Us | Contact Us | Feedback | Sitemap | Privacy Policy | Payment Policy | Browser Compatibility

Follow us

Copyright © Amdavad Municipal Corporation
Powered by Tata Consultancy Services Ltd.